EFA at European Health Stakeholder Meeting in the European Parliament
On September 12th, EFA participated in a panel-discussion in the European Parliament on “Brexit: the European Parliaments’ role in prioritising patients,...
EFA response to HMA public consultation on allergen product development
In April, the network of Heads of Medicines Agencies in the EU (HMA) launched a public consultation on common regulatory approaches for allergen products....
WHO publishes 2019 report on the global tobacco epidemic
The World Health Organisation (WHO) has published the 7th WHO Report on the Global Tobacco Epidemic. This year, the report focused on the progress that...
CONNECARE – personalized connected care for complex chronic patients
Seven out of 10 hospital beds across Europe are occupied by people with chronic long-term conditions. The EU funded CONNECARE project aims at developing,...
International awareness days – great opportunities for patient groups
International awareness days are an opportunity to educate the general public on specific issues. Especially for patient organisations, it is a great possibility...
CURE project shows good mid-term results
Despite great advances in research, unfortunately, there is still no cure for asthma. The CURE project, funded by the EU, is looking at possible innovative...
Danish politicians tested for allergies
In September, EFA member Asthma and Allergy Denmark has carried out a campaign specially focussed on the lack of specialists and asking for greater capacity...
Back to school – Being prepared with allergy
EFA member Allergy UK has collected a variety of resources for students, parents and carers to empower parents and children feeling safe in school despite...
Food allergen regulation around the world
EFA member Dutch Food Allergies Foundation, has shared an interactive chart providing interesting information on food allergen regulation around the world....
COPD: Substances at work have same effect as smoking
EFA member Long Fonds has published results of a research indicating that substances at work can cause COPD when being inhaled. The study carried out by...
Outdoor public places smoke-free in Sweden
The Swedish government banned smoking in outdoor public places from July 1st. The following places should now be smoke-free: entrances to public buildings,...
Survey on the use of lay language summaries in paediatric clinical trials
The European Forum of Good Clinical Practices (EFGCP) in collaboration with the European Federation of Pharmaceutical Industries and Association (EFPIA)...
EFA Statement of Condolence on the Death of Hubert Nettel, EFA Board Member and Treasurer
Sep 24, 2019
Brussels, Belgium (September 24, 2019) – Mikaela Odemyr, president of the European Federation ofAllergy and Airways Diseases Patients’...
EFA launches European report "Active Patients Access Care"
EFA eagerly launches its new European report “Active Asthma and COPD Patients ACCESS Care”. The report unveils new patient evidence on asthma and COPD patients’ access to diagnosis and care, involvement in the care they receive through empowerment and prevention.
EFA signs joint letter to Politico after promotion of Tobacco Industry
EFA has signed a joint open letter to politico.eu, a Brussels based online magazine covering European politics, policy and governmental affairs. The magazine...
Join us on the 2nd World Atopic Eczema Day on September 14th
On September 14th, EFA, together with Global Skin, is marking World Atopic Eczema Day. With the day’s theme BENEATH THE SURFACE we raise awareness and...
EFA at the Patient Access Partnership conference on the Future of Health
On 11 and 12 July, EFA was proud to contribute to the high-level conference of Patient Access Partnership (PACT) on ‘The Future of Health: Advancing...
Save the Date: World Atopic Eczema Day 14th September
On September 14th, EFA together with Global Skin we are marking the 2nd World Atopic Eczema Day with the theme BENEATH THE SURFACE to raise awareness and...
EFA response to EMA consultation on allergen product development in low-sized populations
The European Medicines Agency (EMA) launched a public consultation on the basis of a concept paper for a ‘Guideline for allergen products development...
EFA Response to EMA Public Consultation on Patient Registries
The European Medicines Agency (EMA) launched a public consultation on the basis of a discussion paper focusing on the “use of patient disease registries...